SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-015295
Filing Date
2022-04-22
Accepted
2022-04-22 17:07:11
Documents
15
Period of Report
2022-04-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K life-8k_20220422.htm   iXBRL 8-K 55495
2 EX-1.1 life-ex11_28.htm EX-1.1 268612
3 EX-5.1 life-ex51_15.htm EX-5.1 19195
4 GRAPHIC giv44eaib12n000001.jpg GRAPHIC 33607
  Complete submission text file 0001564590-22-015295.txt   583685

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA life-20220422.xsd EX-101.SCH 5701
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE life-20220422_lab.xml EX-101.LAB 19431
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE life-20220422_pre.xml EX-101.PRE 11588
9 EXTRACTED XBRL INSTANCE DOCUMENT life-8k_20220422_htm.xml XML 3558
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37378 | Film No.: 22846421
SIC: 2836 Biological Products, (No Diagnostic Substances)